Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Jimi

Showing results (91-100 of 96) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 96 results.
Biotherapy (Dordrecht, Netherlands)|January 1, 1989
Clinical evaluation of sizofiran combined with irradiation in patients with cervical cancer. A randomized controlled study; a five-year survival rateK Okamura, M Suzuki, T Chihara, et al.
FEBS Letters|January 15, 1998
Stimulation of cell-surface urokinase-type plasminogen activator activity and cell migration in vascular endothelial cells by a novel hexapeptide analogue of neurotensinS Ushiro, K Mizoguchi, S Yoshida, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 10, 1999
Efficient nuclear delivery of antisense oligodeoxynucleotides and selective inhibition of CETP expression by apo E peptide in a human CETP-stably transfected CHO cell lineK Liu, J Ou, K Saku, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Angiogenesis as a new target for cancer treatmentM Ono, H Izumi, S Yoshida, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1982
[FT-207 maintenance therapy of malignant gynecologic cancer]Y Kidera, H Sugimori, M Tanaka, et al.
Nihon Gan Chiryo Gakkai Shi|August 20, 1981
[Long-term chemotherapy with FT-207 for ovarian cancer (author's transl)]H Sugimori, M Tanaka, S Jimi, et al.
Pageof 10

Showing results (91-100 of 96) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 96 results.
Biotherapy (Dordrecht, Netherlands)|January 1, 1989
Clinical evaluation of sizofiran combined with irradiation in patients with cervical cancer. A randomized controlled study; a five-year survival rateK Okamura, M Suzuki, T Chihara, et al.
FEBS Letters|January 15, 1998
Stimulation of cell-surface urokinase-type plasminogen activator activity and cell migration in vascular endothelial cells by a novel hexapeptide analogue of neurotensinS Ushiro, K Mizoguchi, S Yoshida, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 10, 1999
Efficient nuclear delivery of antisense oligodeoxynucleotides and selective inhibition of CETP expression by apo E peptide in a human CETP-stably transfected CHO cell lineK Liu, J Ou, K Saku, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Angiogenesis as a new target for cancer treatmentM Ono, H Izumi, S Yoshida, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1982
[FT-207 maintenance therapy of malignant gynecologic cancer]Y Kidera, H Sugimori, M Tanaka, et al.
Nihon Gan Chiryo Gakkai Shi|August 20, 1981
[Long-term chemotherapy with FT-207 for ovarian cancer (author's transl)]H Sugimori, M Tanaka, S Jimi, et al.
Pageof 10